Latest 10-Q quarterly reports

Piermont Valley Acquisition Corp. reports on its Q2 2026 financial status, highlighting progress on its merger with Tigerless Health Inc. while acknowledging substantial doubt about its going concern.

Harte Hanks announced its second quarter 2026 financial results, revealing a net loss and declining revenues, while also detailing a pending merger with Star Equity Holdings.

PodcastOne, Inc. filed its Form 10-Q for the quarter ended June 30, 2026, reporting an 8% increase in revenue to $16.1 million but also a net loss of $1.6 million, with ongoing concerns about liquidity and the ability to continue as a going concern.

Amass Brands Inc. reported a significant increase in net loss for Q2 2026, driven by higher operating expenses and impairment charges, despite a modest increase in net revenues.

TransCode Therapeutics reports increased operating losses and a continued need for capital, with cash reserves projected to last only until year-end 2026.

StablecoinX Inc. files its Q2 2026 10-Q, detailing a significant net loss of $34.2 million, largely due to a $36.2 million impairment of digital intangible assets, following its recent business combination.

TruGolf Holdings, Inc. announced its Q2 2026 financial results, showing a 34.4% increase in revenue to $5.79 million, but also reporting a net loss of $0.45 million.

LiveOne, Inc. filed its Q1 FY27 Form 10-Q, reporting a net loss of $3.1 million and a working capital deficiency, raising substantial doubt about its ability to continue as a going concern.

GSR V Acquisition Corp. reports on its second quarter ending June 30, 2026, detailing its ongoing search for a business combination and its financial position, primarily consisting of funds held in trust.

Nexscient, Inc. reported its second quarter 2026 financial results, highlighting the consolidation of its recent Flipside AI acquisition, which introduced revenue but also contributed to increased operating expenses and net loss.

Longevity Health Holdings, Inc. filed its Q2 2026 10-Q, revealing a significant net loss, declining sales, and substantial doubt about its ability to continue as a going concern.

Keen Vision Acquisition Corporation's Q2 2026 report details Nasdaq delisting, ongoing business combination search, and significant share redemptions, raising concerns about its future viability.

OS Therapies Inc. reported substantial Q2 2026 losses and a going concern warning, despite positive clinical trial results for its lead candidate OST-HER2.

MediaCo Holding Inc. reported a net loss of $8.6 million for Q2 2026, with revenues increasing 9% year-over-year, but operating expenses also rose, contributing to ongoing financial concerns.

All In FutureTech Alliance, Inc. (formerly Allied Gaming & Entertainment Inc.) reported a net loss for the second quarter of 2026, with revenues declining across its in-person and casual mobile gaming segments, while also recording substantial impairments.

Change Agents Corporation (CHGA) filed its quarterly report for the period ended June 30, 2026, detailing a significant reduction in net loss but highlighting ongoing financial challenges and a substantial doubt about its ability to continue as a going concern.

ByNordic Acquisition Corporation's Q2 2026 filing reveals continued efforts to secure a business combination, with extensions granted up to August 2027, alongside significant accumulated deficits and ongoing liquidity concerns.

Berto Acquisition Corp. II, a SPAC, reported its financial results for the second quarter ended June 30, 2026, detailing its IPO proceeds and ongoing search for a business combination.

BioNexus Gene Lab Corp. filed its Q2 2026 report, detailing a substantial decrease in revenue and continued operational losses, while also addressing internal control deficiencies and strategic initiatives.

Berto Acquisition Corp. reported a net income of $1.11 million for Q2 2026, driven by investment income, while continuing its search for a business combination.

Bone Biologics Corporation's Q2 2026 Form 10-Q highlights ongoing net losses and a substantial accumulated deficit, raising concerns about its ability to continue as a going concern despite recent capital raises.

Axe Compute Inc. reported a significant increase in revenue for Q2 2026, driven by its Compute Services segment, but also disclosed substantial net losses and increased operating expenses.

Helix Acquisition Corp. III reports net income driven by trust account interest, with ongoing efforts to identify a business combination within its 24-month window.

Mountain Crest Acquisition Corp. V's Q2 2026 Form 10-Q reveals significant challenges, including Nasdaq delisting and continued uncertainty regarding its business combination, alongside a net loss for the period.

PetVivo Holdings reported increased revenues for Q1 2027, but faces substantial doubt regarding its ability to continue as a going concern due to ongoing net losses and accumulated deficit.

HealthLynked Corp. reported a significant decline in revenue for the second quarter of 2026, with patient service revenue down 60% and a widening net loss, raising concerns about its going concern status.

Liminatus Pharma, Inc. filed its Q2 2026 Form 10-Q, detailing continued operational losses, a substantial accumulated deficit, and ongoing efforts to regain Nasdaq listing compliance.

FiEE, Inc. showcases substantial revenue growth driven by its strategic shift to SaaS and digital services, alongside acquisitions, while addressing ongoing financial and internal control challenges.

Bally's Corporation filed its Form 10-Q for the quarter ended June 30, 2026, reporting increased revenue but a substantial net loss and ongoing liquidity challenges.

Stemtech Corporation's Q2 2026 Form 10-Q reveals a significant decline in net sales and continued net losses, highlighting ongoing financial pressures and operational constraints.